Skip to content

Ayahuasca: all studies

Page 95 of 167: studies 941 to 950 of 1,662, newest first. Back to the ayahuasca overview

Research

Church of the Holy Light of the Queen v. Mukasey

February 27, 2023 Henrique Fernandes Antunes 2 citations

The purpose of this chapter is to analyze the legal dispute between the US government and a Santo Daime church—the Church of the Holy Light of the Queen (CHLQ), located in Ashland, Oregon—that culminated in the regulation process of ayahuasca in that state. Initially, I will briefly describe the insertion of the Santo Daime into the United States, the beginning of tensions with the governmental...

DOI: 10.4324/9780429001161-3 (opens in new tab) Ayahuasca Government linguistics State computer science Law +2

Psychedelics Legislation Gains Momentum

Psychiatric News February 16, 2023 Terri D'Arrigo

Bills that would decriminalize the use of psychedelics are popping up faster than magic mushrooms, but the field of psychedelics research has yet to yield supporting evidence about their safety and efficacy. Legislative reform regarding psychedelics is gaining ground, a study in JAMA Psychiatry has found. From January 1, 2019, to September 28, 2022, 25 states considered 74 bills that proposed...

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Frontiers in Psychiatry February 10, 2023 Muhammad Ishrat Husain, Nicole Ledwos, Elise Fellows et al. 47 citations

Introduction Current treatment options for major depressive disorder (MDD) have limited efficacy and are associated with adverse effects. Recent studies investigating the antidepressant effect of serotonergic psychedelics—also known as classic psychedelics—have promising preliminary results with large effect sizes. In this context, we conducted a review of the putative neurobiological...

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.

Journal of Affective Disorders February 1, 2023 Kwonmok Ko, Emma I Kopra, Anthony J. Cleare et al. 144 citations

Psychedelic therapy shows promise for Major Depressive Disorder, especially when treatment-resistant, as well as life-threatening illness distress. The objective of this systematic review, inclusive of meta-analysis, is to examine recent clinical research on the therapeutic effects of classic psychedelics on depressive symptoms. Fourteen psychedelic therapy studies, utilising psilocybin,...

Indigenous-Amazonian Traditional Medicine’s Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study

Plants January 11, 2023 Ilana Berlowitz, Ernesto García Torres, Caroline Maake et al. 14 citations

Harmful usage of tobacco is a global public health problem associated with adverse health effects and addiction. Yet, in the Peruvian Amazon, the native region of Nicotiana rustica L., this plant is used in remarkably different manners: it is considered a potent medicinal plant, applied in liquid form for oral ingestion to treat mental health problems, a common and ancient healing practice in...

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Journal of Psychoactive Drugs 2023 Aviad Hadar, Jonathan David, Nadav Shalit et al. 93 citations

Psychedelics were used in the treatment of psychiatric conditions prior to their prohibition in the late 1960s. In the past three decades, there is a revived research interest in the therapeutic potential of psychedelic drugs with expected FDA approvals for treatment of various conditions. Given the exponential scientific growth of this field, we sought to characterize, analyze, and visualize...

A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.

Frontiers in Pharmacology 2023 Klemens Egger, Frederik Gudmundsen, Naja Støckel Jessen et al. 17 citations

Rationale: The psychedelic effects of the traditional Amazonian botanical decoction known as ayahuasca are often attributed to agonism at brain serotonin 5-HT2A receptors by N,N-dimethyltryptamine (DMT). To reduce first pass metabolism of oral DMT, ayahuasca preparations additionally contain reversible monoamine oxidase A (MAO-A) inhibitors, namely β-carboline alkaloids such as harmine....

The varieties of psychedelic law

Neuropharmacology December 21, 2022 Mason Marks 59 citations

After decades of prohibition, psychedelics are generating intense public and private interest. Scientists are researching the therapeutic properties of these substances, and mounting evidence supports their ability to treat a variety of mental health conditions. Meanwhile, dozens of cities and states are proposing or enacting psychedelics legislation to promote research, increase therapeutic...

DOI: 10.1016/j.neuropharm.2022.109399 (opens in new tab) Ayahuasca Psilocybin Controlled substance regulation Psychedelics policy reform +4

The woman who chose the terreiro. Lay care and medical landscapes in mental health care in Rio de Janeiro.

Anthropology & medicine December 1, 2022 Manuela R Müller, Francisco Ortega, Angel Martínez-Hernáez 13 citations

Brazilian mental health care reform understands mental health as a complex social process. There is a large literature production within the country focused on deinstitutionalization policy, social determinants of mental health and human rights, however, with little recognition beyond Latin American borders. In addition, cultural dimensions of mental suffering have been neglected in Brazilian...

DOI: 10.1080/13648470.2022.2144131 (opens in new tab) Full text (opens in new tab) Ayahuasca Cultural determinants Self-care Mental health treatment +4